234 related articles for article (PubMed ID: 30526144)
1. Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B/AMPK/eNOS/NO signalling pathway.
Feng L; Ren J; Li Y; Yang G; Kang L; Zhang S; Ma C; Li J; Liu J; Yang L; Qi Z
Free Radic Res; 2019 Jan; 53(1):82-93. PubMed ID: 30526144
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol attenuates myocardial ischemia/reperfusion injury through up-regulation of vascular endothelial growth factor B.
Yang L; Zhang Y; Zhu M; Zhang Q; Wang X; Wang Y; Zhang J; Li J; Yang L; Liu J; Liu F; Yang Y; Kang L; Shen Y; Qi Z
Free Radic Biol Med; 2016 Dec; 101():1-9. PubMed ID: 27667182
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway.
Zhang X; Huang LF; Hua L; Feng HK; Shen B
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1789-1796. PubMed ID: 30840305
[TBL] [Abstract][Full Text] [Related]
4. κ-opioid receptor activation protects against myocardial ischemia-reperfusion injury via AMPK/Akt/eNOS signaling activation.
Zhang S; Zhou Y; Zhao L; Tian X; Jia M; Gu X; Feng N; An R; Yang L; Zheng G; Li J; Guo H; Fan R; Pei J
Eur J Pharmacol; 2018 Aug; 833():100-108. PubMed ID: 29856969
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats.
Ding M; Lei J; Han H; Li W; Qu Y; Fu E; Fu F; Wang X
Cardiovasc Diabetol; 2015 Oct; 14():143. PubMed ID: 26489513
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol prevents ISO-induced myocardial remodeling associated with regulating polarization of macrophages through VEGF-B/AMPK/NF-kB pathway.
Li Y; Feng L; Li G; An J; Zhang S; Li J; Liu J; Ren J; Yang L; Qi Z
Int Immunopharmacol; 2020 Jul; 84():106508. PubMed ID: 32339921
[TBL] [Abstract][Full Text] [Related]
8. Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways.
Pan C; Lou L; Huo Y; Singh G; Chen M; Zhang D; Wu A; Zhao M; Wang S; Li J
Ther Adv Cardiovasc Dis; 2011 Apr; 5(2):99-111. PubMed ID: 21282198
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium.
Penumathsa SV; Thirunavukkarasu M; Zhan L; Maulik G; Menon VP; Bagchi D; Maulik N
J Cell Mol Med; 2008 Dec; 12(6A):2350-61. PubMed ID: 18266981
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation.
Gao F; Gao E; Yue TL; Ohlstein EH; Lopez BL; Christopher TA; Ma XL
Circulation; 2002 Mar; 105(12):1497-502. PubMed ID: 11914261
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
[TBL] [Abstract][Full Text] [Related]
12. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.
Thirunavukkarasu M; Penumathsa SV; Koneru S; Juhasz B; Zhan L; Otani H; Bagchi D; Das DK; Maulik N
Free Radic Biol Med; 2007 Sep; 43(5):720-9. PubMed ID: 17664136
[TBL] [Abstract][Full Text] [Related]
14. Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.
Gaballa MA; Raya TE; Hoover CA; Goldman S
Cardiovasc Res; 1999 Jun; 42(3):627-35. PubMed ID: 10533602
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin ameliorated inflammation and oxidative stress in isoproterenol induced myocardial infarction through the endothelial nitric oxide synthase (eNOS)/nuclear factor erythroid 2-related factor-2 (NRF2)/heme oxygenase-1 (HO-1) signaling pathway.
El-Shaer NO; El Gazzar WB; Allam MM; Anwer HM
J Physiol Pharmacol; 2021 Apr; 72(2):. PubMed ID: 34642258
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
17. Protective Effect of Resveratrol against Ischemia-Reperfusion Injury via Enhanced High Energy Compounds and eNOS-SIRT1 Expression in Type 2 Diabetic Female Rat Heart.
Fourny N; Lan C; Sérée E; Bernard M; Desrois M
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30621358
[TBL] [Abstract][Full Text] [Related]
18. The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats.
Savergnini SQ; Ianzer D; Carvalho MB; Ferreira AJ; Silva GA; Marques FD; Peluso AA; Beiman M; Cojocaru G; Cohen Y; Almeida AP; Rotman G; Santos RA
PLoS One; 2013; 8(3):e57757. PubMed ID: 23469229
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol, novel application by preconditioning to attenuate myocardial ischemia/reperfusion injury in mice through regulate AMPK pathway and autophagy level.
Li H; Zheng F; Zhang Y; Sun J; Gao F; Shi G
J Cell Mol Med; 2022 Aug; 26(15):4216-4229. PubMed ID: 35791579
[TBL] [Abstract][Full Text] [Related]
20. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart.
Das S; Alagappan VK; Bagchi D; Sharma HS; Maulik N; Das DK
Vascul Pharmacol; 2005; 42(5-6):281-9. PubMed ID: 15905131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
